tiprankstipranks
Trending News
More News >
Multi-Chem Limited (SG:AWZ)
SGX:AWZ

Multi-Chem Limited (AWZ) AI Stock Analysis

Compare
16 Followers

Top Page

SG

Multi-Chem Limited

(SGX:AWZ)

Rating:81Outperform
Price Target:
S$3.50
▲(11.82%Upside)
Multi-Chem Limited's strong financial performance and attractive valuation are the primary drivers of its high score. The company's robust cash management and low leverage enhance its growth potential. Technical analysis indicates stable market conditions, supporting the positive outlook.

Multi-Chem Limited (AWZ) vs. iShares MSCI Singapore ETF (EWS)

Multi-Chem Limited Business Overview & Revenue Model

Company DescriptionMulti-Chem Limited, an investment holding company, distributes information technology products in Singapore, Greater China, Australia, India, and internationally. It operates through two segments, Printed Circuit Board (PCB) Business and IT Business. The company distributes hardware and software relating to internet and network products, as well as related installation, technical, and maintenance services. It also offers PCB related services to PCB fabricators. In addition, the company distributes a range of specialty chemicals; and PCB-related materials and equipment, including entry and back-up materials for drilling, non-woven brushes to ensure clean copper surface with suitable roughness, tacky rollers, tack cloth/wipes, cleaning machine to remove foreign particles on PCBs, automatic drills regrinding machines, and x-ray inspection machines. Further, it leases machines; offers software consultancy and implementation services; and provides IT training courses. Multi-Chem Limited was incorporated in 1985 and is headquartered in Singapore.
How the Company Makes MoneyMulti-Chem Limited makes money through the sale and distribution of specialty chemicals and related equipment. The company's primary revenue streams come from supplying products to industries such as electronics manufacturing, oil and gas extraction, and pharmaceutical production. By forming strategic partnerships with leading chemical manufacturers, Multi-Chem ensures a steady supply of high-demand products, which it then sells to its clients. Additionally, the company offers technical support and maintenance services, providing an additional revenue stream that complements its core distribution activities. These services help to build long-term relationships with clients and secure repeat business, contributing significantly to the company's overall earnings.

Multi-Chem Limited Financial Statement Overview

Summary
Multi-Chem Limited exhibits strong financial health across all verticals. The income statement shows solid revenue growth and consistent profit margins, though the absence of EBIT in 2024 is a concern. The balance sheet is robust, with low leverage and effective equity utilization, despite a slight dip in the equity ratio. The cash flow statement underscores excellent cash generation and management. Overall, the company is well-positioned for future growth, with minor areas for improvement.
Income Statement
85
Very Positive
Multi-Chem Limited has demonstrated solid revenue growth with a 6.7% increase from 2022 to 2023 and stable gross profit margins around 14.4%. While EBIT margin was non-existent in 2024, the previous years showed consistent EBIT performance. The net profit margin held steady at around 4.1%, indicating stable profitability. Overall, the income statement reflects a strong growth trajectory and stable profitability, although the lack of EBIT in 2024 requires attention.
Balance Sheet
79
Positive
The company maintains a low debt-to-equity ratio of 0.01, reflecting prudent leverage management. Return on Equity (ROE) was approximately 17.5% in 2023, demonstrating effective use of equity. The equity ratio of 38.6% denotes a healthy financial position, though slightly lower than previous years due to increased liabilities. Overall, the balance sheet is strong, with low leverage and solid equity management, though the slightly decreasing equity ratio warrants attention.
Cash Flow
88
Very Positive
Free cash flow grew by 45.4% from 2022 to 2023, highlighting strong cash generation capabilities. The operating cash flow to net income ratio is robust at 1.35, indicating efficient cash conversion. The free cash flow to net income ratio of 1.33 further supports the company's strong cash generation. Overall, the cash flow statement reflects excellent cash management and growth, positioning the company well for future investments.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue658.42M683.68M616.98M603.64M479.71M
Gross Profit94.79M97.48M87.01M85.51M71.64M
EBITDA39.25M42.64M28.14M38.36M28.46M
Net Income27.12M30.82M20.00M24.96M17.78M
Balance Sheet
Total Assets402.43M381.61M329.30M298.44M273.41M
Cash, Cash Equivalents and Short-Term Investments83.82M73.54M69.54M74.41M77.65M
Total Debt2.19M2.69M3.42M5.01M7.60M
Total Liabilities248.22M237.40M192.21M168.25M146.58M
Stockholders Equity155.25M145.25M137.10M130.20M114.53M
Cash Flow
Free Cash Flow36.12M24.84M10.97M25.78M45.85M
Operating Cash Flow36.64M25.19M12.12M26.95M47.14M
Investing Cash Flow128.00K-304.00K-939.00K-896.00K-1.59M
Financing Cash Flow-27.29M-20.35M-14.50M-20.15M-27.18M

Multi-Chem Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.13
Price Trends
50DMA
3.08
Positive
100DMA
3.05
Positive
200DMA
2.85
Positive
Market Momentum
MACD
<0.01
Negative
RSI
53.53
Neutral
STOCH
95.56
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:AWZ, the sentiment is Positive. The current price of 3.13 is above the 20-day moving average (MA) of 3.10, above the 50-day MA of 3.08, and above the 200-day MA of 2.85, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.53 is Neutral, neither overbought nor oversold. The STOCH value of 95.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:AWZ.

Multi-Chem Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
SGAWZ
81
Outperform
€281.10M9.1222.42%9.10%
63
Neutral
$34.04B6.14-11.52%1.82%5.53%-18.79%
$176.87M21.1325.02%5.13%
SG8AZ
79
Outperform
S$451.50M6.4020.62%34.19%-30.65%-29.55%
SGE28
69
Neutral
S$542.40M14.618.89%2.63%6.93%14.19%
SGJLB
64
Neutral
S$324.02M29.208.66%0.31%43.32%96.93%
SGAWX
55
Neutral
S$466.93M39.622.40%-20.96%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:AWZ
Multi-Chem Limited
3.13
0.48
18.29%
MCRNF
Micro-Mechanics (Holdings)
1.28
0.16
14.29%
SG:8AZ
Aztech Global Ltd.
0.58
-0.24
-29.27%
SG:AWX
AEM Holdings Ltd.
1.45
-0.37
-20.33%
SG:E28
Frencken Group Limited
1.26
-0.36
-22.22%
SG:JLB
Grand Venture Technology Limited
0.98
0.41
71.93%

Multi-Chem Limited Corporate Events

Multi-Chem Limited Conducts Annual General Meeting with Poll Voting
May 22, 2025

Multi-Chem Limited held its Annual General Meeting on April 25, 2025, in Singapore, where key company directors and shareholders were present. The meeting was chaired by Mr. Chong Teck Sin, and all resolutions were voted on by poll, with Entrust Advisory Pte Ltd appointed as the scrutineer. The Chairman exercised his right to demand poll voting for all resolutions and ensured that proxy votes were cast in accordance with shareholders’ instructions.

Multi-Chem Limited Shifts to Half-Yearly Financial Reporting
Apr 9, 2025

Multi-Chem Limited has announced a change in its financial reporting schedule, moving from quarterly to half-yearly reporting of unaudited financial statements, starting from the financial year ending December 31, 2025. This strategic shift is aimed at consolidating resources in a challenging economic environment to foster continued growth and value creation, while maintaining compliance with disclosure obligations to keep shareholders informed of any significant developments.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 26, 2025